Skip to main content

LadRx Corp

LADXDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000799698

LadRx Corp was delisted in 2025; its insiders filed their last Form 4 on Jan 29, 2024; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding LadRx Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of LADX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders110
Shares14.3K1.00K−13.3K (−93.0%)
Value$1.00K$115−$885 (−88.5%)

New holders (1)

Institutions that held LadRx Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to LADX in Q4 2022
InstitutionSharesValue% of portfolio
Archer Investment Corp1,000$1150.00%

Sold out (1)

Institutions that held LadRx Corp at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of LADX in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
First Heartland Consultants, Inc.14,300$1.00K